|Bid||69.81 x 900|
|Ask||69.98 x 800|
|Day's Range||67.85 - 69.87|
|52 Week Range||60.14 - 82.15|
|Beta (3Y Monthly)||1.26|
|PE Ratio (TTM)||22.86|
|Earnings Date||Feb 20, 2019|
|Forward Dividend & Yield||2.00 (2.95%)|
|1y Target Est||88.57|
CNBC's Jim Cramer eyes the week ahead, which will feature earnings reports from Walmart, CVS and more. "If we get a [trade] deal ... I think the stocks of many international companies ... can rally because at this point the earnings estimates are too low," Cramer says. Norwegian Cruise "could be the standout that potentially reignites the whole group, which is dirt cheap," the "Mad Money" host says.
A group of six office buildings in a prime Triad submarket have been sold for $25 million. Dominion Realty Partners of Raleigh and Blue Vista Capital Management of Chicago have partnered on the acquisition of six buildings with 386,844 square feet of office space in Mendenhall Business Park in High Point.
WOONSOCKET, R.I. , Feb. 15, 2019 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced that Eva Boratto , executive vice president and chief financial officer, will be speaking to investors ...
NEW YORK, Feb. 15, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Prominent hedge fund managers sold out of Chinese technology stocks and dumped Silicon Valley majors such as Apple Inc and Facebook Inc while global stock markets cratered during the fourth quarter, according to securities filings released on Thursday. Activist hedge fund Jana Partners sold out of its position in major Chinese e-commerce company Alibaba Group Holding Ltd and reduced its stake in Apple by approximately 175,000 shares, slicing its position in the company by 63 percent. Warren Buffett's Berkshire Hathaway Inc shrank its Apple stake to 249.6 million shares from 252.5 million shares in the fourth quarter.
Medtronic (MDT) is expected to maintain a decent market share in the core pacing backed by the continued uptake of Micra Transcatheter Pacing System in Q3.
Shares of CVS Health (CVS) have popped 4% in the last month and jumped 1.16% during regular trading Wednesday. But does this signal that investors expect good things from the pharmacy power's Q4 financial results that are due out before the opening bell on February 20?
What Did 2018 Bring for Moat Stocks?(Continued from Prior Part)VanEck New Year, New Positioning The U.S. Moat Index is reviewed quarterly to ensure the Index is allocated to companies that Morningstar believes possess a sustainable competitive
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.